Arkolith/Insider Trading/AUPH/Form 4

Tang Kevin

Chief Executive Officer, Director, 10% OwnerAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Jun 3, 2026
Net Buying
Open-Market Buys
$12.5M
Open-Market Sells
$0
Net Open-Market Flow
$12.5M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Buy(P)206K$15.28$3.1M13.0M
Jun 1, 2026Buy(P)344K$15.28$5.2M12.8M
Jun 1, 2026Buy(P)99$15.34$2K12.8M
May 29, 2026Buy(P)2K$15.35$35K12.2M
May 29, 2026Buy(P)263K$15.31$4.0M12.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 2, 2026Other(J)10K$1.65$17K10K

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178579-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML